FBT - Latest News

First Trust NYSE Arca Biotechnology Index Fund (FBT), operates in Financial Services / Asset Management, trades on AMEX.

Market capitalization stands near $1.64B, a proxy for assets under management on listed ETFs.

The article list below shows the most recent FBT headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent FBT Headlines

Better Biotechnology ETF: First Trust FBT vs. VanEck BBH

fool.com - Oct 10, 2026

The First Trust NYSE Arca Biotechnology Index Fund has outperformed the VanEck Biotech ETF on a one-year basis and over the last five years. The VanE

Biotech ETFs to Buy as Cancer Drug Breakthroughs Accelerate

zacks.com - Sep 21, 2026

Biotech ETFs offer diversified exposure to oncology innovation as cancer funding surges and the global oncology drug market expands.

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?

zacks.com - Sep 11, 2026

A smart beta exchange traded fund, the First Trust NYSE Arca Biotechnology ETF (FBT) debuted on 06/19/2006, and offers broad exposure to the Health Ca

Which Is the Better Healthcare ETF: Fidelity's Low-Cost FHLC or First Trust's High-Conviction FBT?

fool.com - Sep 10, 2026

One fund offers broad sector exposure at 0. 08% cost; the other concentrates on 30 biotech stocks with higher volatility but stronger recent returns.

Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?

zacks.com - Sep 1, 2026

Launched on June 19, 2006, the First Trust NYSE Arca Biotechnology ETF (FBT) is a passively managed exchange traded fund designed to provide a broad e

How News Affects FBT Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track FBT's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked FBT news questions

What is the latest FBT news headline?

The most recent FBT headline (Oct 10, 2026) is "Better Biotechnology ETF: First Trust FBT vs. VanEck BBH". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the FBT news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What FBT news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual FBT options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.